Synthesis of Evidence to Quantify Value
The evidence required for submissions to health authorities and decision makers continues to evolve, requiring increasingly sophisticated methods to demonstrate value. Meeting the evidence demands for reimbursement and optimal pricing requires thorough analyses of the current research conducted to date to identify key value drivers, data gaps, and comparative effects across therapies, along with a team of experts that can integrate findings into the overall value proposition. Evidera’s expert team of scientists, modelers and statisticians has developed hundreds of simulations, statistical models, and literature reviews to support reimbursement, market access, and internal decision making in all major therapeutic indications and across all major markets.
